Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Schindeldecker

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Translational Oncology|December 28, 2019
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell CarcinomaPhilipp J Stenzel, Mario Schindeldecker, Katrin E Tagscherer, et al.
International Journal of Cancer|November 2, 2023
Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancerKatharina Frei, Sabrina Schecher, Tamas Daher, et al.
Cancers|July 9, 2022
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological ConsiderationsTiemo S Gerber, Lukas Müller, Fabian Bartsch, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Cancers|January 21, 2022
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeDirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, et al.
Cancers|July 9, 2022
N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the PancreasTiemo S Gerber, Benjamin Goeppert, Anne Hausen, et al.
Cancers|April 12, 2022
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile CancerAnita Thomas, Kimberly Sue Slade, Roman A Blaheta, et al.
JCI Insight|August 10, 2021
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisCarolin Czauderna, Alicia Poplawski, Colm J O'Rourke, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Translational Oncology|December 28, 2019
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell CarcinomaPhilipp J Stenzel, Mario Schindeldecker, Katrin E Tagscherer, et al.
International Journal of Cancer|November 2, 2023
Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancerKatharina Frei, Sabrina Schecher, Tamas Daher, et al.
Cancers|July 9, 2022
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological ConsiderationsTiemo S Gerber, Lukas Müller, Fabian Bartsch, et al.
Cancers|June 2, 2021
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile CancerAnita Thomas, Sascha Reetz, Philipp Stenzel, et al.
Cancers|January 21, 2022
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable OutcomeDirk Andreas Ridder, Lana Louisa Urbansky, Hagen Roland Witzel, et al.
Cancers|July 9, 2022
N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the PancreasTiemo S Gerber, Benjamin Goeppert, Anne Hausen, et al.
Cancers|April 12, 2022
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile CancerAnita Thomas, Kimberly Sue Slade, Roman A Blaheta, et al.
JCI Insight|August 10, 2021
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesisCarolin Czauderna, Alicia Poplawski, Colm J O'Rourke, et al.
Pageof 3